The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of mifepristone (M), carboplatin (C), and gemcitabine (G) in advanced breast and ovarian cancer.
 
Erica Michelle Stringer
Honoraria - Breast Cancer Index
Research Funding - Corcept Therapeutics (Inst)
Travel, Accommodations, Expenses - Cascadian Therapeutics
 
Poornima Saha
No Relationships to Disclose
 
April Swoboda
No Relationships to Disclose
 
Masha Kocherginsky
Patents, Royalties, Other Intellectual Property - Royalties - co-inventor on Patent 9149485, "Methods and compositions related to glucocorticoid receptor antagonists and breast cancer".
 
Gabrielle Baker
No Relationships to Disclose
 
Simona Olberkyte
No Relationships to Disclose
 
Nana Owusu
No Relationships to Disclose
 
Brittany Dyer
No Relationships to Disclose
 
Lauren Olalde
No Relationships to Disclose
 
Elizabeth Olszewski
No Relationships to Disclose
 
Olwen Mary Hahn
Honoraria - Cardinal Health (I)
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Philip C. Hoffman
No Relationships to Disclose
 
Brooke Elizabeth Phillips
No Relationships to Disclose
 
Grace K. Suh
No Relationships to Disclose
 
Suzanne D. Conzen
No Relationships to Disclose
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
Other Relationship - Aeterna Zentaris
 
Rita Nanda
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche; Novartis; Peregrine Pharmaceuticals; Pfizer; Puma Biotechnology
Research Funding - Celgene; Corcept Therapeutics; Merck